Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Argus Health
Cantor Fitzgerald
AstraZeneca
Merck
Covington

Generated: July 21, 2019

DrugPatentWatch Database Preview

Litigation Details for DatCard Systems Inc v. PacsGear Inc (C.D. Cal. 2010)

Try a free trialSee Plans and Pricing

« Back to Dashboard

DatCard Systems Inc v. PacsGear Inc (C.D. Cal. 2010)

Docket ➤ Sign Up Date Filed 2010-08-23
Court District Court, C.D. California Date Terminated 2013-04-01
Cause 35:271 Patent Infringement Assigned To Mariana R. Pfaelzer
Jury Demand Both Referred To Victor B. Kenton
Parties DATCARD SYSTEMS INC; PACSGEAR INC
Patents 10,066,017; 8,044,046; 8,067,025; 8,114,021; 9,109,010
Attorneys Brian Christopher Claassen; Bridget Anne Smith; Craig S Summers; David H Chan; Dennis G Martin; Paul A Stewart; Willmore F Holbrow , III
Firms Blakely Sokoloff Taylor and Zafman LLP; Knobbe Martens Olson & Bear LLP
Link to Docket External link to docket
Small Molecule Drugs cited in DatCard Systems Inc v. PacsGear Inc
The small molecule drugs covered by the patents cited in this case are ➤ Sign Up , ➤ Sign Up , and ➤ Sign Up .
Biologic Drugs cited in DatCard Systems Inc v. PacsGear Inc

The biologic drugs covered by the patents cited in this case are ➤ Sign Up , ➤ Sign Up , and ➤ Sign Up .

Details for DatCard Systems Inc v. PacsGear Inc (C.D. Cal. 2010)

Date Filed Document No. Description Snippet Link To Document
2012-11-16 156 Transcript (CV) 86:20, 99:12, 71:18, 73:23, 88:10, 66:17, 66:23, 67:6, 50:19, 53:25, 79:19 …anticipation of the '174 patent, the '597 4 patent and the '164 patent. 5 …to 23 the '174 patent, the '597 patent, and the '164 patent. 24 THE…argument on two of the patents today 15 but put the search and burn patents on hold and allow the… What's in the 17 patent? The text is not in the patent. 18 MR. HOLBROW External link to document
2012-01-16 67 Memorandum in Support of Motion server searches for “related data.” Col. 24 8:44-46. The only data identified as being stored on these…THE ‘174 PATENT 20 21 A. Claim Construction Of The ‘174 Patent …does not infringe three of the five patents in suit: U.S. Patents 4 Nos.,7,302,164 B2, reissued …invalidity and non-infringement of the ‘422 patent, because that patent 18 centers on a technical issue …the complete ‘164 patent as Appendix A, followed 27 by the claims of each patent in readable type External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Covington
Colorcon
Baxter
Medtronic
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.